Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Fraser, Simon D S ^a   Aitken, Grant ^b   Taal, Maarten W ^c   Mindell, Jennifer S ^d   Moon, Graham ^b   Day, Julie ^e   O'Donoghue, Donal ^f   Roderick, Paul J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ROYAL VICTORIA INFIRMARY   (United Kingdom)

^f SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MICROALBUMINURIA; MORTALITY; MUSCLE MASS; PREDICTION; PREVALENCE; RISK ASSESSMENT; SMOKING CESSATION; UNITED KINGDOM; URINALYSIS; ENGLAND; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SEVERITY OF ILLNESS INDEX; URINE;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CYSTATIN C; ENGLAND; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84923683618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118676     Document Type: Article

References (46)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Executive summary. Am J Kidney Dis.2002; 39: S17-31
2. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: 247-254. PMID: 16908915
3. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3: 150.
4. NICE clinical guideline 73: Chronic kidney disease; early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Institute for Health and Clinical Excellence, 2008.
5. th 2014.
6. th 2014.
7. th 2014.
8. Moynihan R, Glassock R, Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ. 2013; 347: f4298 doi: 10.1136/bmj.f4298 PMID: 23900313
9. Levey AS, Stevens LA, Schmid CH. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612. PMID: 19414839
10. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012; 307: 1941-1951. doi: 10.1001/jama.2012.3954 PMID: 22570462
11. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 150.
12. th 2014.
13. O'Callaghan CA, Shine B, Lasserson DS. Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open. 2011; 1: e000308. doi: 10.1136/bmjopen-2011-000308 PMID: 22184586
14. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073-2081. doi: 10.1016/S0140- 6736(10)60674-5 PMID: 20483451
15. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013; 346: f324. doi: 10.1136/bmj.f324 PMID: 23360717
16. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol. 2007; 8: 2749-2757.
17. Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010; 56: 486-495. doi: 10.1053/j.ajkd.2010.03.026 PMID: 20557989
18. Tangri N, Stevens LA, Schmid CH, Zhang YL, Beck GJ, Greene T, et al. Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int. 2011; 79: 471-477. doi: 10.1038/ki.2010.431 PMID: 20980977
19. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008; 3: 348-354. doi: 10.2215/CJN.02870707 PMID: 18235143
20. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005; 352: 2049-2060. PMID: 15901858
21. Kottgen A, Selvin E, Stevens LA, Levey AS, van Lente FJ, Coresh J. Serum Cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2008; 51: 385-394. doi: 10.1053/j.ajkd.2007.11.019 PMID: 18295054
22. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008; 51: 395-406. doi: 10.1053/j.ajkd.2007.11.018 PMID: 18295055
23. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012; 367: 20-29. doi: 10.1056/ NEJMoa1114248 PMID: 22762315
24. Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011; 305: 1545-1552. doi: 10.1001/jama. 2011.468 PMID: 21482744
25. Craig R, Hirani V (Eds.) Health Survey for England 2009. Health and lifestyles. Leeds: The NHS Information Centre for Health and Social Care. 2010.
26. Craig R, Mindell J (Eds.) Health Survey for England 2010. Respiratory health. Leeds: The NHS Information Centre for Health and Social Care. 2011.
27. Jordan H, Roderick P, Martin D. The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health. 2004; 58: 250-257. PMID: 14966241
28. National Institute for Health and Clinical Excellence. NICE clinical guideline 43. Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. 2006.
29. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994; 40: 1921-1926. PMID: 7923773
30. Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005; 51:1420-1431. PMID: 15961546
31. th 2014.
32. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis. 2010; 55: 660-670. doi: 10.1053/j.ajkd.2009.12.011 PMID: 20138414
33. Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, et al. Trends in the prevalence of reduced GFR in the United States: A comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis. 2013; 62: 253-260. doi: 10.1053/j.ajkd.2013.03.013 PMID: 23619125
34. Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med. 2008; 121: 341-348. doi: 10.1016/j.amjmed.2008.01. 003 PMID: 18374694
35. Servais A, Giral P, Bernard M, Bruckert E, Deray G, Isnard Bagnis C. Is serum cystatin-C a reliable marker for metabolic syndrome? Am J Med. 2008; 121: 426-432. doi: 10.1016/j.amjmed.2008.01.040 PMID: 18456039
36. Peralta CA, Katz R, Sarnak MJ, Ix J, Fried LF, De Boer I, et al. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol. 2011; 22: 147-155. doi: 10.1681/ ASN.2010050483 PMID: 21164029
37. Rule AD, Glassock RJ. GFR estimating equations: getting closer to the truth? Clin J Am Soc Nephrol. 2013; 8:1414-1420. doi: 10.2215/CJN.01240213 PMID: 23704300
38. Waheed S, Matsushita K, Astor BC, Hoogeveen RC, Ballantyne C. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol. 2013; 8: 434-442. doi: 10.2215/CJN.04960512 PMID: 23258794
39. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013; 369: 932-943. doi: 10.1056/ NEJMoa1214234 PMID: 24004120
40. Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013; 158: 596-603. doi: 10. 7326/0003-4819-158-8-201304160-00004 PMID: 23588748
41. th 2014.
42. NHS Employers and British Medical Association. Quality and Outcomes Framework guidance for GMS contract 2011/12. Delivering investment in general practice. 2011.
43. de Lusignan S, Tomson C, Harris K, van Vlymen J, Gallagher H. Creatinine fluctuation has a greater effect than the formula to estimate glomerular filtration rate on the prevalence of chronic kidney disease. Nephron Clin Pract. 2011; 117: 213-224.
44. Voskoboev NV, Larson TS, Rule AD, Lieske JC.Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate. Clin Chem Lab Med. 2012; 50: 1591-1596. doi: 10.1515/cclm-2012-0063 PMID: 22962219
45. Voskoboev NV, Larson TS, Rule AD, Lieske JC. Importance of cystatin C assay standardization. Clin Chem. 2011; 57: 1209-1211. doi: 10.1373/clinchem.2011.164798 PMID: 21666068
46. Shlipak MG, Weekley CC, Li Y, Hansson LO, Larsson A, Whooley M. Comparison of cardiovascular prognosis by 3 serum cystatin C methods in the Heart and Soul Study. Clin Chem. 2011; 57: 737-745. doi: 10.1373/clinchem.2010.158915 PMID: 21310869